-
-
-
-
-
-
-
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
-
-
-
-
-
-
-
Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition
-
-
-
-
-
-
-
CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatme
-
-
-
-
-
-
-
CytoMed Therapeutics (GDTC) Acquires Cord Blood Banking Licence and Assets
-
-
-
-
-
-
-
CytoMed Therapeutics (GDTC) Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
-
-
-
-
-
-
-
CytoMed Therapeutics (GDTC) Granted Patent in China for Licensed Allogeneic CAR-Gamma Delta T Cell Technology
-
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

